Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model
- PMID: 15592573
- DOI: 10.1038/nm1162
Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model
Abstract
Here we report that epidermal keratinocytes in psoriatic lesions are characterized by activated Stat3. Transgenic mice with keratinocytes expressing a constitutively active Stat3 (K5.Stat3C mice) develop a skin phenotype either spontaneously, or in response to wounding, that closely resembles psoriasis. Keratinocytes from K5.Stat3C mice show upregulation of several molecules linked to the pathogenesis of psoriasis. In addition, the development of psoriatic lesions in K5.Stat3C mice requires cooperation between Stat3 activation in keratinocytes and activated T cells. Finally, abrogation of Stat3 function by a decoy oligonucleotide inhibits the onset and reverses established psoriatic lesions in K5.Stat3C mice. Thus, targeting Stat3 may be potentially therapeutic in the treatment of psoriasis.
Comment in
-
Psoriasis: more than skin deep.Nat Med. 2005 Jan;11(1):17-8. doi: 10.1038/nm0105-17. Nat Med. 2005. PMID: 15635435 No abstract available.
Similar articles
-
Psoriasis: more than skin deep.Nat Med. 2005 Jan;11(1):17-8. doi: 10.1038/nm0105-17. Nat Med. 2005. PMID: 15635435 No abstract available.
-
Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.Oncogene. 2008 Feb 14;27(8):1087-94. doi: 10.1038/sj.onc.1210726. Epub 2007 Aug 13. Oncogene. 2008. PMID: 17700521
-
Stat3 activation in epidermal keratinocytes induces Langerhans cell activation to form an essential circuit for psoriasis via IL-23 production.J Dermatol Sci. 2019 Feb;93(2):82-91. doi: 10.1016/j.jdermsci.2018.11.007. Epub 2018 Nov 23. J Dermatol Sci. 2019. PMID: 30514663
-
Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases.J Dermatol Sci. 2008 Apr;50(1):1-14. doi: 10.1016/j.jdermsci.2007.05.016. Epub 2007 Jul 2. J Dermatol Sci. 2008. PMID: 17601706 Review.
-
Animal models of psoriasis.Clin Dermatol. 2007 Nov-Dec;25(6):596-605. doi: 10.1016/j.clindermatol.2007.08.014. Clin Dermatol. 2007. PMID: 18021898 Review.
Cited by
-
miR-124-3p Delivered Using Exosomes Attenuates the Keratinocyte Response to IL-17A Stimulation in Psoriasis.Oxid Med Cell Longev. 2022 Oct 12;2022:6264474. doi: 10.1155/2022/6264474. eCollection 2022. Oxid Med Cell Longev. 2022. Retraction in: Oxid Med Cell Longev. 2023 Jun 21;2023:9876751. doi: 10.1155/2023/9876751 PMID: 36275890 Free PMC article. Retracted.
-
Noncytotoxic Inhibition of the Immunoproteasome Regulates Human Immune Cells In Vitro and Suppresses Cutaneous Inflammation in the Mouse.J Immunol. 2021 Apr 1;206(7):1631-1641. doi: 10.4049/jimmunol.2000951. Epub 2021 Mar 5. J Immunol. 2021. PMID: 33674446 Free PMC article.
-
Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer.Cancer Res. 2012 Jul 1;72(13):3135-42. doi: 10.1158/0008-5472.CAN-11-3195. Epub 2012 Apr 24. Cancer Res. 2012. PMID: 22532166 Free PMC article.
-
Upregulation of ANGPTL6 in mouse keratinocytes enhances susceptibility to psoriasis.Sci Rep. 2016 Oct 4;6:34690. doi: 10.1038/srep34690. Sci Rep. 2016. PMID: 27698489 Free PMC article.
-
Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis.Cancer Res. 2010 Apr 15;70(8):3287-98. doi: 10.1158/0008-5472.CAN-09-3467. Epub 2010 Apr 13. Cancer Res. 2010. PMID: 20388784 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous